Apotex Can't Dodge Schering Suit Over Nasonex IP
U.S. District Judge Garrett E. Brown Jr. denied Canadian drugmaker Apotex's motion for summary judgment of noninfringement. He filed his opinion under seal to give the companies seven days to propose redactions.
Schering, a subsidiary of Merck & Co. Inc., filed suit in December...
To view the full article, register now.